Nitric oxide down-regulates caveolin-1 expression in rat brains during focal cerebral ischemia and reperfusion injury

Journal of Neurochemistry

Volumn 96, Issue 4, 2006, Pages 1078-1089

  Shen, Jiangang ^a,b,d   Ma, Stephanie ^b   Chan, Puishan ^a   Lee, Waisin ^a   Fung, Peter C W ^b   Cheung, Raymond T F ^b   Tong, Yao ^c   Liu, Ke Jian ^d  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c THE UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Caveolin 1; Ischemic stroke; Nitric oxide; Nitric oxide synthase

Indexed keywords

7 NITROINDAZOLE; CAVEOLIN 1; CAVEOLIN 2; COMPLEMENTARY DNA; INDUCIBLE NITRIC OXIDE SYNTHASE; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE METHYL ESTER; N6 (1 IMINOETHYL)LYSINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; ENZYME INHIBITION; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; STROKE; WESTERN BLOTTING;

ANIMALS; BRAIN ISCHEMIA; CAVEOLIN 1; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; ORNITHINE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

ANIMALIA;

EID: 33645107784     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03589.x     Document Type: Article

References (57)

1. Arvanitis DN. Wang H. Bagshaw RD. Callahan JW. Boggs JM. 2004 Membrane-associated estrogen receptor and caveolin-1 are present in central nervous system myelin and oligodendrocyte plasma membranes JNeurosciRes 75 603 613
2. Ashwal S. Tone B. Tian HR. Cole DJ. Pearce WJ. 1998 Core and penumbral nitric oxide synthase activity during cerebral ischemia and reperfusion Stroke 29 1037 1046
3. Beckman JS. Koppenol WH. 1996 Nitric oxide, superoxide and peroxynitrite: The good, the bad, the ugly AmJPhysiol 271 C1424 C1437
4. Bu J. Bruckner SR. Sengoku T. Geddes JW. Estus S. 2003 Glutamate regulates caveolin expression in rat hippocampal neurons JNeurosciRes 72 185 190
5. Cameron RS. Ruffin JW. Cho NK. Cameron PL. Rakic P. 1997a Developmental expression, pattern of distribution, and effect on cell aggregation implicate a neuron-glial junctional domain protein in neuronal migration JCompNeurol 387 467 488
6. Cameron PL. Ruffin JW. Bollag R. Rasmussen H. Cameron RS. 1997b Identification of caveolin and caveolin-related proteins in the brain JNeurosci 17 9520 9535
7. Carver LA. Schnitzer JE. 2003 Caveolae, mining little caves for new cancer targets NatRevCancer 3 571 581
8. Cheung RT. Hachinski VC. Cechetto DF. 1997 Cardiovascular response to stress after middle cerebral artery occlusion in rats Brain Res 747 181 188
9. Cohen AW. Combs TP. Scherer PE. Lisanti MP. 2003 Role of caveolin and caveolae in insulin signaling and diabetes AmJPhysiolEndocrinolMetab 285 E1151 E1160
10. Dirnagl U. Lindauer U. Them A. Schreiber S. Pfister HW. Koedel U. Reszka R. Freyer D. Villringer A. 1995 Global cerebral ischemia in the rat: online monitoring of oxygen free radical production using chemiluminescence in vivo JCerebBlood Flow Metab 15 929 940
11. Everson WV. Smart EJ. 2001 Influence of caveolin, cholesterol, and lipoproteins on nitric oxide synthase: implications for vascular disease Trends CardiovascMed 11 246 250
12. Felley-Bosco E. Bender FC. Courjault-Gautier F. Bron C. Quest AF. 2000 Caveolin-1 down-regulates inducible nitric oxide synthase via the proteasome pathway in human colon carcinoma cells ProcNatl AcadSciUSA 97 14 334 14 339
13. Feron O. Belhassen L. Kobzik L. Smith TW. Kelly RA. Michel T. 1996 Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells JBiolChem 271 22 810 22 814
14. Fielding CJ. Fielding PE. 2001 Caveolae and intracellular trafficking of cholesterol AdvDrugDelivRev 49 251 264
15. Frank PG. Lisanti MP. 2004 Caveolin-1 and caveolae in atherosclerosis: differential roles in fatty streak formation and neointimal hyperplasia CurrOpinLipidol 15 523 529
16. Galbiati F. Volonte D. Gil O. et al. 1998 Expression of caveolin-1 and -2 in differentiating PC12 cells and dorsal root ganglion neurons: caveolin-2 is up-regulated in response to cell injury ProcNatlAcadSciUSA 95 10257 10262
17. Galbiati F. Volonte D. Liu J. Capozza F. Frank PG. Zhu L. Pestell RG. Lisanti MP. 2001 Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21 (WAF1/Cip1)-dependent mechanism MolBiolCell 12 2229 2244
18. Garcia-Cardena G. Martasek P. Masters BS. Skidd PM. Couet J. Li S. Lisanti MP. Sessa WC. 1997 Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the NOS caveolin binding domain in vivo JBiolChem 272 25437 25440
19. Gaudreault SB. Dea D. Poirier J. 2004 Increased caveolin-1 expression in Alzheimer's disease brain NeurobiolAging 25 753 759
20. Glenney JR. Jr. Soppet D. 1992 Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts ProcNatlAcadSciUSA 89 10 517 10 521
21. Goligorsky MS. Li H. Brodsky S. Chen J. 2002 Relationships between caveolae and eNOS: everything in proximity and the proximity of everything AmJPhysiolRenal Physiol 283 F1 F10
22. Ikezu T. Ueda H. Trapp BD. et al. 1998 Affinity-purification and characterization of caveolins from the brain: differential expression of caveolin-1, -2, and -3 in brain endothelial and astroglial cell types Brain Res 804 177 192
23. -ΔΔCt method Methods 25 402 408
24. Leker RR. Teichner A. Ovadia H. Keshet E. Reinherz E. Ben-Hur T. 2001 Expression of endothelial nitric oxide synthase in the ischemic penumbra: relationship to expression of neuronal nitric oxide synthase and vascular endothelial growth factor Brain Res 909 1 7
25. Lerouet D. Beray-Berthat V. Palmier B. Plotkine M. Margaill I. 2002 Changes in oxidative stress, iNOS activity and neutrophil infiltration in severe transient focal cerebral ischemia in rats Brain Res 958 166 175
26. Li H. Brodsky S. Basco M. Romanov V. De Angelis DA. Goligorsky MS. 2001 Nitric oxide attenuates signal transduction: possible role in dissociating caveolin-1 scaffold CircRes 88 229 236 q25
27. Lisanti MP. Scherer PE. Tang Z. Sargiacomo M. 1994 Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis Trends Cell Biol 4 231 235
28. Liu J. Lee P. Galbiati F. Kitsis RN. Lisanti MP. 2001 Caveolin-1 expression sensitizes fibroblastic and epithelial cells to apoptotic stimulation AmJPhysiolCell Physiol 280 C823 C835
29. Longa EZ. Weinstein PR. Carlson S. Cummins R. 1989 Reversible middle cerebral artery occlusion without craniectomy in rats Stroke 20 84 91
30. Mahmoudi M. Willgoss D. Cuttle L. Yang T. Pat B. Winterford C. Endre Z. Johnson DW. Gobe GC. 2003 In vivo and in vitro models demonstrate a role for caveolin-1 in the pathogenesis of ischaemic acute renal failure JPathol 200 396 405
31. Malinski T. Bailey F. Zhang ZG. Chopp M. 1993 Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion JCerebBlood Flow Metab 13 355 358
32. Marletta MA. 1994 Nitric oxide synthase: aspects concerning structure and catalysis Cell 78 927 930
33. Massimino ML. Griffoni C. Spisni E. Toni M. Tomasi V. 2002 Involvement of caveolae and caveolae-like domains in signalling, cell survival and angiogenesis Cell Signal 14 93 98
34. Matsui T. Nagafuji T. Kumanishi T. Asano T. 1999 Role of nitric oxide in pathogenesis underlying ischemic cerebral damage Cell MolNeurobiol 19 177 189
35. Mikol DD. Scherer SS. Duckett SJ. Hong HL. Feldman EL. 2002 Schwann cell caveolin-1 expression increases during myelination and decreases after axotomy Glia 38 191 199
36. Moncada S. Palmer RM. Higgs EA. 1991 Nitric oxide: physiology, pathophysiology, and pharmacology PharmacolRev 43 109 142
37. Muijsers RB. Folkerts G. Henricks PA. Sadeghi-Hashjin G. Nijkamp FP. 1997 Peroxynitrite: a two-faced metabolite of nitric oxide Life Sci 60 1833 1845
38. Navarro-Lerida I. Portoles MT. Barrientos AA. Gavilanes F. Bosca L. Rodriguez-Crespo I. 2004 Induction of nitric oxide synthase-2 proceeds with the concomitant downregulation of the endogenous caveolin levels JCell Sci 117 1687 1697
39. Niwa M. Inao S. Takayasu M. Kawai T. Kajita Y. Nihashi T. Kabeya R. Sugimoto T. Yoshida J. 2001 Time course of expression of three nitric oxide synthase isoforms after transient middle cerebral artery occlusion in rats NeurolMedChir(Tokyo) 41 63 72
40. Parat MO. Stachowicz RZ. Fox PL. 2002 Oxidative stress inhibits caveolin-1 palmitoylation and trafficking in endothelial cells BiochemJ 361 681 688
41. Peterson TE. Poppa V. Ueba H. Wu A. Yan C. Berk BC. 1999 Opposing effects of reactive oxygen species and cholesterol on endothelial nitric oxide synthase and endothelial cell caveolae CircRes 85 29 37
42. Phillips PG. Birnby LM. 2004 Nitric oxide modulates caveolin-1 and matrix metalloproteinase-9 expression and distribution at the endothelial cell/tumor cell interface AmJPhysiolLung Cell MolPhysiol 286 L1055 L1065
43. Ratajczak P. Damy T. Heymes C. Oliviero P. Marotte F. Robidel E. Sercombe R. Boczkowski J. Rappaport L. Samuel JL. 2003 Caveolin-1 and -3 dissociations from caveolae to cytosol in the heart during aging and after myocardial infarction in rat CardiovascRes 57 358 369
44. Razani B. Combs TP. Wang XB. Frank PG. Park DS. Russell RG. Li M. Tang B. Jelicks LA. Scherer PE. Lisanti MP. 2002 Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities JBiolChem 277 8635 8647
45. Rothberg KG. Heuser JE. Donzell WC. Ying YS. Glenney JR. Anderson RG. 1992 Caveolin, a protein component of caveolae membrane coats Cell 68 673 682
46. Sato S. Tominaga T. Ohnishi T. Ohnishi ST. 1994 Electron paramagnetic resonance study on nitric oxide production during brain focal ischemia and reperfusion in the rat Brain Res 647 91 96
47. Scherer PE. Lisanti MP. Baldini G. Sargiacomo M. Mastick CC. Lodish HF. 1994 Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles JCell Biol 127 1233 1243
48. Scherer PE. Okamoto T. Chun M. Nishimoto I. Lodish HF. Lisanti MP. 1996 Identification, sequence, and expression of caveolin-2 defines a caveolin gene family ProcNatl AcadSciUSA 93 131 135
49. Shutenko A. Henry Y. Pinard E. Seylaz J. Potier P. Berthet F. Girard P. Sercombe R. 1999 Influence of the antioxidant quercetin in vivo on the level of nitric oxide determined by electron paramagnetic resonance in rat brain during global ischemia and reperfusion BiochemPharmacol 57 199 208
50. Song KS. Scherer PE. Tang Z. Okamoto T. Li S. Chafel M. Chu C. Kohtz DS. Lisanti MP. 1996 Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins JBiolChem 271 15 160 15 165
51. Tominaga T. Sato S. Ohnishi T. Ohnishi ST. 1993 Potentiation of nitric oxide formation following bilateral carotid occlusion and focal cerebral ischemia in the rat: in vivo detection of the nitric oxide radical by electron paramagnetic resonance spin trapping Brain Res 614 342 346
52. Tominaga T. Sato S. Ohnishi T. Ohnishi ST. 1994 Electron paramagnetic resonance (EPR) detection of nitric oxide produced during forebrain ischemia of the rat JCerebBlood Flow Metab 14 715 722
53. Venema VJ. Ju H. Zou R. Venema RC. 1997 Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain JBiolChem 272 28 187 28 190
54. Woodman SE. Sotgia F. Galbiati F. Minetti C. Lisanti MP. 2004 Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases Neurology 62 538 543
55. Young LH. Ikeda Y. Lefer AM. 2001 Caveolin-1 peptide exerts cardioprotective effects in myocardial ischemia-reperfusion via nitric oxide mechanism AmJPhysiolHeart CircPhysiol 280 H2489 H2495
56. Zschocke J. Manthey D. Bayatti N. van der Burg B. Goodenough S. Behl C. 2002 Estrogen receptor alpha-mediated silencing of caveolin gene expression in neuronal cells JBiolChem 277 38 772 38 780
57. Zschocke J. Manthey D. Bayatti N. Behl C. 2003 Functional interaction of estrogen receptor alpha and caveolin isoforms in neuronal SK-N-MC cells JSteroid BiochemMolBiol 84 167 170